Regulation, suspicion slow U.S. flu response: hearing

November 18, 2009
by Maggie Fox, Health and Science Editor

WASHINGTON (Reuters) - Vaccine makers praised the U.S. response to the swine flu pandemic on Wednesday but said regulatory delays and public suspicion have held up innovative ways to speed and stretch the U.S. influenza vaccine supply.

"We have moved as fast as or faster than any other country in the world," said Jeffrey Levi, executive director of the non-profit Trust for America's Health, which has in the past criticized U.S. preparedness for pandemics.

View the full story (some sites require registration)